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Purpose: To compare tear ﬁlm parameters as well as meibomian gland morphologic features and function
among patients with meibomian gland dysfunction (MGD), those with noneSjögren syndrome aqueous-deﬁcient
dry eye (non-SS ADDE), those with non-SS ADDE and MGD, and normal subjects.
Design: Multicenter, cross-sectional, observational case series.
Participants: Forty-one eyes of 41 patients (all women; mean age  standard deviation, 62.19.9 years) with
non-SS ADDE, 70 eyes of 70 patients (all women; 66.08.7 years) with MGD, 17 eyes of 17 patients (all women;
72.47.8 years) with non-SS ADDE and MGD, and 70 eyes of 70 normal control subjects (all women; 65.07.1
years).
Methods: Ocular symptoms were scored from 0 to 14 and lid margin abnormalities from 0 to 4 according to
their respective number. Meibomian gland changes were scored from 0 to 6 (meiboscore) on the basis of
noncontact meibography ﬁndings, and meibum was graded from 0 to 3 depending on its volume and quality.
Conjunctival and corneal epithelial damage were scored from 0 to 9 (ﬂuorescein score). Tear ﬁlm break-up time
(TBUT) was measured as an index of tear ﬁlm stability, and tear ﬂuid production was evaluated with Schirmer’s
test.
Main Outcome Measures: Ocular symptom score, lid margin abnormality score, meiboscore, meibum
grade, ﬂuorescein score, TBUT, and Schirmer’s test value.
Results: The ocular symptom score did not differ signiﬁcantly between the MGD and non-SS ADDE groups
(P ¼ 0.762). The lid margin abnormality score, meiboscore, and meibum grade were signiﬁcantly higher in the
MGD group than in the non-SS ADDE group (P ¼ 0.0012, P < 0.0001, and P < 0.0001, respectively). The
ﬂuorescein score, TBUT, and Schirmer’s test value were signiﬁcantly worse in the non-SS ADDE group than in the
MGD group (P < 0.0001, P ¼ 0.0061, and P < 0.0001, respectively). The meiboscore correlated signiﬁcantly with
Schirmer’s test value only in the MGD group (r ¼ 0.508, P ¼ 8.3106).
Conclusions: An increase in tear ﬂuid production likely compensates for loss of meibomian glands in
individuals with MGD. Ophthalmology 2015;122:925-933 ª 2015by theAmericanAcademyofOphthalmology. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Homeostasis in living organisms refers to the maintenance
of a relatively stable milieu despite changes in internal or
external conditions.1,2 The concept of homeostasis thus has
been thought to be applicable to automatically controlled
systems. The existence of homeostasis in the tear ﬁlm has
been suggested,3 but the role of components of the tear ﬁlm
in such homeostasis has not been evaluated.
The tear ﬁlm is composed of an aqueous layer produced
by lacrimal glands as well as an overlying oily layer, the
lipid components of which are secreted by meibomian
glands. Dry eye is a disorder of the tear ﬁlm caused by tear
deﬁciency or excessive tear evaporation, and it can result in
damage to the interpalpebral ocular surface. This condition 2015 by the American Academy of Ophthalmology
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by Elsevier Inc.is associated with symptoms of ocular discomfort,4 and
various mechanisms and deﬁnitions have been proposed.5
Dry eye thus has been divided into 2 main categories:
aqueous-deﬁcient dry eye (ADDE) and evaporative dry
eye (EDE).5 NoneSjögren syndrome (non-SS) ADDE is a
common subtype of ADDE, whereas meibomian gland
dysfunction (MGD) is a major cause of EDE.6 Although
non-SS ADDE and MGD account for most cases of dry
eye, the relationship between clinical parameters in ADDE
and those in EDE has remained unclear.
We hypothesized that the aqueous and oily layers of the
tear ﬁlm may compensate for each other to maintain
homeostasis at the ocular surface. To investigate the concept925http://dx.doi.org/10.1016/j.ophtha.2014.12.018
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Ophthalmology Volume 122, Number 5, May 2015of homeostasis in the tear ﬁlm, we compared tear ﬁlm pa-
rameters as well as the function and morphologic features of
meibomian glands among individuals with non-SS ADDE,
those with MGD, those with both conditions, and normal
controls.
Methods
Subjects
This study was approved by the Institutional Review Boards of The
University of Tokyo, Yamaguchi University, Osaka University
Hospital, Keio University School of Medicine, Nihon University
Itabashi Hospital, and Itoh Clinic, and it adhered to the tenets of the
Declaration of Helsinki. Written informed consent was obtained
from all subjects before examination.
Clinical Examinations
Women older than 40 years of age who reported dry eye symp-
toms, who did not have systemic disease or a past history of ocular
surgery, and who were not taking oral medications or applying
topical eyedrops with the exception of artiﬁcial tears were
considered to be potential patients for this study. Those individuals
who used artiﬁcial tears were instructed not to apply them for at
least 2 hours before examinations. Individuals with a punctal plug
were excluded. Patients who were scheduled to undergo cataract
surgery were examined for enrollment as normal subjects, and the
clinical examinations were performed before the surgery.
All physicians (R.A., N.M., S.K., R.S., M.K., T.S., and T.S.)
who examined candidate subjects were specialists in the ﬁeld of
ocular surface. Data were obtained from the right eye of each
subject unless this eye was excluded from the study, in which case
data were collected from the left eye. Examinations were per-
formed sequentially as follows. (1) All patients were questioned
regarding the absence or presence of 14 ocular symptoms
(Table 1). Symptoms were scored from 0 through 14 according to
the number present. (2) Abnormalities of the upper and lower lid
margins (Table 1) were scored from 0 through 4 according to the
number present. (3) Fluorescein staining of the ocular surface
was divided into 3 zones comprising nasal conjunctival, corneal,
and temporal conjunctival areas.7 The staining score ranged from
0 to 3 for each zone, yielding a total score of 0 to 9 for the
ocular surface.7 (4) Tear ﬁlm break-up time (TBUT) wasTable 1. Clinical Parameter
Examination
Ocular symptoms Ocular fatigue, discharge, foreign body sensation
redness, heavy sensation, glare, excessive blin
Lid margin abnormality Irregular lid margin, vascular engorgement, plug
mucocutaneous junction
Fluorescein staining Nasal conjunctiva (0e3), cornea (0e3), tempo
Tear ﬁlm break-up time Less than 5 seconds: decreased
Meiboscore Grade 0: no dropout
Grade 1: dropout of <1/3 of lid area
Grade 2: dropout of 1/3e2/3 of lid area
Grade 3: dropout of >2/3 of lid area
Total meiboscore (0e6): upper eyelid þ lower
Schirmer’s test Less than 5 mm: decreased
Meibum grade Grade 0: clear meibum readily expressed
Grade 1: cloudy meibum expressed with mild p
Grade 2: cloudy meibum expressed with more t
Grade 3: meibum not expressed even with stron
926measured after instillation of 1 ml of a preservative-free solution of
1% ﬂuorescein dye into the conjunctival sac with the use of a
micropipette, and the subjects were asked to blink several times.
The TBUT was measured 3 times consecutively with a stopwatch,
and the mean of the 3 values was calculated. (5) The upper and
lower eyelids were evaluated with the use of a noncontact mei-
bography system, and the meibomian glands were observed. Partial
or complete loss of meibomian glands was scored according to the
meiboscore for each eyelid as previously described (Table 1).8 The
meiboscores for the upper and lower eyelids were summed to
obtain a score from 0 to 6 for each eye. (6) A Schirmer strip
(Whatman no. 41; Showa, Tokyo, Japan) was inserted over the
lower lid margin, midway between the middle and outer thirds,
for 5 minutes without topical anesthesia. Subjects were asked to
close their eyes during the measurement. Schirmer’s test thus
was performed within the limits of evaluable situations. (7)
Digital pressure was applied to the upper tarsus, and the degree
of ease with which meibomian secretion (meibum) was induced
was evaluated semiquantitatively (Table 1).9
After these clinical examinations, the candidate subjects were
classiﬁed into 4 groups (Fig 1). The normal group included
subjects who fulﬁlled the following criteria: (1) ocular symptom
score of less than 3, (2) no tear ﬁlm abnormality (Schirmer’s test
value of 5 mm and TBUT of 5 seconds), and (3) no
abnormalities of the lid margins or meibum. The non-SS ADDE
group comprised subjects who met the following conditions that
conform to the deﬁnition of dry eye proposed by the Dry Eye
Research Group in Japan10: (1) the presence of dry eye symptoms,
(2) abnormal tear production as determined by Schirmer’s test (<5
mm after 5 minutes) or abnormal tear ﬁlm stability as determined
by TBUT (<5 seconds), and (3) the presence of conjunctival and
corneal epithelial damage as evidenced by a ﬂuorescein staining
score of 3, according to the van Bijsterveld method.7 Patients
with Sjögren syndrome were excluded. The MGD group
included subjects who fulﬁlled the diagnostic criteria for
obstructive MGD11: (1) the presence of ocular symptoms (ocular
symptom score of 3), (2) at least 1 lid margin abnormality, and
(3) poor meibum secretion (meibum grade of 1 to 3). The non-
SS ADDE and MGD group comprised candidates who fulﬁlled
the entry criteria for both non-SS ADDE and MGD groups.
Exclusion criteria for all subjects included ocular allergies, contact
lens wear, a history of eye surgery, and systemic or ocular diseases
that may interfere with tear ﬁlm production or function. Individuals
whose eyes showed excessive meibomian lipid secretion also were
excluded. The normal, non-SS ADDE, MGD, and non-SS ADDEs and Their Evaluation
Evaluation
, dryness, uncomfortable sensation, sticky sensation, pain, epiphora, itching,
king, history of chalazion or hordeolum
ged meibomian gland oriﬁces, anterior or posterior replacement of the
ral conjunctiva (0e3)
eyelid
ressure
han moderate pressure
g pressure
Figure 1. Flowchart showing participant progress through the study. ADDE ¼ aqueous-deﬁcient dry eye; MGD ¼ meibomian gland dysfunction;
non-SS ¼ noneSjögren syndrome; TBUT ¼ tear ﬁlm break-up time.
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deviation, 65.07.1 years), 41 (62.19.9 years), 70 (66.08.7
years), and 17 (72.47.8 years) subjects, respectively.
Statistical Analysis
Data for all parameters are presented as mean  standard deviation
and were compared among non-SS ADDE, MGD, non-SS ADDE
and MGD, and control groups with the use of the Steel-Dwass test.
Regression curves comparing meiboscore and Schirmer’s test
value were calculated on the basis of scatterplots and were eval-
uated with Spearman’s rank-correlation coefﬁcient (r). A P value
of less than 0.05 was considered statistically signiﬁcant.
Results
Representative lid margin, ﬂuorescein staining, and meibography
ﬁndings for normal control, non-SS ADDE, and MGD subjects are
shown in Figures 2, 3, and 4, respectively. No loss of meibomian
glands and only minimal meibomian gland changes were observed
in the normal control (Fig 2) and non-SS ADDE (Fig 3) subjects,
respectively. In contrast, various meibomian gland changes,
including dropout, shortening, distortion, and dilation, were
apparent in the MGD subject (Fig 4).
Data for the clinical parameters in each group of study subjects
and the P values for pairwise comparisons of the values among the
4 groups are presented in Tables 2 and 3, respectively. Age did notdiffer signiﬁcantly within each pair of subject groups, with the
exception of pairs including the non-SSADDEandMGDgroup. The
ocular symptom score did not differ signiﬁcantly among the non-SS
ADDE, the MGD, and the non-SS ADDE andMGD groups. The lid
margin abnormality score was signiﬁcantly higher in the MGD and
the non-SS ADDE and MGD groups than in the non-SS ADDE
group (P ¼ 0.0012 and P ¼ 0.0105, respectively). The ﬂuorescein
score was signiﬁcantly higher in the non-SS ADDE and the non-SS
ADDE and MGD groups than in the MGD group (P < 0.0001 and
P < 0.0001). The TBUT was signiﬁcantly shorter in the non-SS
ADDE and the non-SS ADDE and MGD groups than in the MGD
group (P ¼ 0.0061 and P ¼ 0.0017, respectively). The meiboscore
was signiﬁcantly higher in theMGDgroup than in the non-SSADDE
and the non-SS ADDE and MGD groups (P < 0.0001 and
P¼ 0.0012, respectively). Meibum grade was signiﬁcantly higher in
the MGD and the non-SS ADDE and MGD groups than in the non-
SSADDE group (P< 0.0001 andP< 0.0001). Schirmer’s test value
was signiﬁcantly lower in the non-SS ADDE and the non-SS ADDE
and MGD groups than in the MGD group (P < 0.0001 and P <
0.0001). Of note, Schirmer’s test value was actually highest in the
MGD group among the 4 groups of subjects.
A scatterplot and regression curve for Schirmer’s test value
versus meiboscore in each group of subjects are shown in Figure 5.
Spearman’s r was e0.0838 in the normal group, 0.253 in the non-
SS ADDE group, 0.508 in the MGD group, and 0.256 in the
non-SS ADDE and MGD group. A signiﬁcant correlation927
Figure 2. Representative slit-lamp photographs and meibographic images for a normal control subject (62-year-old woman with a Schirmer’s test value of
9 mm and tear ﬁlm break-up time of 8 seconds). A, Slit-lamp photograph of the upper lid margin. B, Slit-lamp photograph of the cornea and conjunctiva
after ﬂuorescein staining and observation with a blue-free ﬁlter. C, D, Noninvasive meibographic images of the upper and lower eyelids, respectively. Note
that no morphologic changes of meibomian glands in either eyelid were apparent (meiboscore of 0).
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(P ¼ 8.3106).Discussion
We compared clinical parameters among normal control
subjects, patients with non-SS ADDE, patients with MGD,
and patients with both conditions. To clarify the relationship
between meibomian gland condition and tear secretion, we
focused on comparison of the non-SS ADDE and MGD
groups. Our data showed that tear ﬂuid secretion (as
reﬂected by Schirmer’s test value) was related closely to the
severity of meibomian gland abnormality (as reﬂected by
the meiboscore, which indicates meibomian gland loss). Our
ﬁndings thus suggested that tear ﬂuid secretion may increase
as a compensatory response to the loss of tear ﬁlm stability
caused by deﬁciency of the oily layer.
Tear secretion in the MGD group increased markedly
according to the extent of meibomian gland loss (meibo-
score). Consistent with our previous observations,11 the
meiboscore was signiﬁcantly higher in the MGD group
than in the other groups. The meiboscore also indicates
the thickness of the oily layer of the tear ﬁlm,12 with a
higher meiboscore corresponding to a thinner oily layer
and consequent tear ﬁlm instability. Tear ﬁlm instability is
associated with a shorter TBUT and results in ocular928surface stimulation and reﬂex tear secretion. Our present
data suggest that tear secretion is increased in patients
with MGD to compensate for the reduced meibomian
gland function and to stabilize the tear ﬁlm. This notion is
consistent with the previous ﬁnding that the tear meniscus
height of patients with MGD is similar to that of normal
controls, whereas that of non-SS ADDE patients is signiﬁ-
cantly lower than that of patients with MGD.13 We also
did not detect a signiﬁcant difference in Schirmer’s test
value between normal subjects and patients with MGD.
Schirmer’s test provides an index of lacrimal gland
function,14,15 whereas meibomian gland area reﬂects mei-
bomian gland function. The fact that a decrease in meibo-
mian gland area is associated with an increase in tear
meniscus height suggests that tear ﬂuid production increases
as a compensatory response to meibomian gland loss to
maintain ocular surface homeostasis. In contrast, we found
that the meiboscore of non-SS ADDE patients was increased
compared with that of normal controls, suggesting that
meibomian gland function was not increased in individuals
with reduced lacrimal gland function. The homeostatic
system of the tear ﬁlm thus may function only 1 way, with
the aqueous layer compensating for deﬁciency of the oily
layer, but not vice versa.
Indeed, in clinical practice, the administration of artiﬁcial
tear eyedrops to some patients with MGD improves ocular
discomfort or the condition of the ocular surface. The
Figure 3. Representative slit-lamp photographs and meibographic images for a noneSjögren syndrome aqueous-deﬁcient dry eye subject (67-year-old
woman with a Schirmer’s test value of 1 mm and tear ﬁlm break-up time of 1 second). A, Slit-lamp photograph of the upper lid margin. B, Slit-lamp
photograph of the cornea and conjunctiva after ﬂuorescein staining and observation with a blue-free ﬁlter. Note that corneal epithelial disorders were
apparent. C, D, Noninvasive meibographic images of the upper and lower eyelids, respectively. Note that minor morphologic changes of meibomian glands
in both upper and lower eyelids were apparent (meiboscore of 1).
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artiﬁcial tears or insertion of punctal plugs may support the
compensatory response to reduced meibomian gland func-
tion. The increase in tear secretion in patients with MGD
also may reduce friction between the eyelid and the cornea
caused by deﬁciency of the oily layer of the tear ﬁlm.
Increased friction during blinking may stimulate the ocular
surface and thereby trigger tear secretion.16 Tear secretion in
patients with MGD thus may increase in response to tear
ﬁlm instability to reduce ocular discomfort.
A previous study demonstrated a compensatory response
of the tear ﬁlm to surgical obstruction of the oriﬁces of
meibomian glands on only 1 side of the eye in a rabbit
model.17 Both Schirmer’s test value and tear ﬁlm osmolarity
in the affected eye were increased compared with those in
the control eye. Tear production also was found
previously to be higher in MGD patients than in ADDE
patients, suggestive of the operation of a compensatory
system in the tear ﬁlm.9 Furthermore, another study found
that tear ﬂow tended to be increased in patients with
MGD compared with control subjects.18 However, a few
reports19,20 describe the relationship between tear secretion
and oily layer, suggesting that a compensatory response to
aqueous deﬁciency remains controversial. Taken together,
these various experimental and clinical observations support
the existence of a compensatory response to a diminished
oily layer by increasing tear ﬂuid.In this study, we determined Schirmer’s test value and the
meiboscore asmeasures of tear ﬂuid secretion andmeibomian
gland abnormality, respectively. The aqueous layer of the tear
ﬁlm is derived primarily from lacrimal glands21 and
constitutes most tear volume. The outermost oily layer of
the tear ﬁlm is produced by meibomian glands.22
Schirmer’s test has been adopted as a common method for
clinical evaluation of tear secretion.5 We previously
evaluated various diagnostic criteria for distinguishing
between subtypes of dry eye disease, and we concluded that
the meiboscore and Schirmer’s test value are the most
reliable parameters measured in the clinic for differentiation
of patients with MGD from those with non-SS ADDE.23
Indeed, a recent multicenter study6 classiﬁed dry eye
disease into 3 categoriesdADDE, MGD, and mixed
typedon the basis of these parameters. Although no gold
standard test for detection of either ADDE or EDE currently
exists, our protocol seems appropriate for this type of
multicenter study.
The TBUT was found to be shorter in the non-SS ADDE
group than in the MGD group. Measurement of TBUT with
ﬂuorescein is one of the most common clinical tests to eval-
uate tear ﬁlm stability. A variety of factors can cause breakup
of the tear ﬁlm.24 Thus, TBUT has been found to depend
mainly on the mucin layer of the tear ﬁlm, the aqueous
layer, and the condition of the ocular surface epithelium.25
Recent studies have shown tear ﬁlm breakup largely is the929
Figure 4. Representative slit-lamp photographs and meibographic images for a meibomian gland dysfunction (MGD) subject (65-year-old woman with
a Schirmer’s test value of 8 mm and tear ﬁlm break-up time of 5 seconds). A, Slit-lamp photograph of the upper lid margin. Lid margin abnormalities,
including vascularity, dislocation of the mucocutaneous junction, and secretion of yellow meibum, were observed. B, Slit-lamp photograph of the cornea and
conjunctiva after ﬂuorescein staining and observation with a blue-free ﬁlter. C, D, Noninvasive meibographic images of the upper and lower eyelids,
respectively. Dropout, shortening, distortion, and dilation of meibomian glands were observed in both eyelids (meiboscore of 5).
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cein also was found to be associated with a more rapid
breakup of the tear ﬁlm.27 We instilled 1 ml of 1% ﬂuorescein
in the subjects of the present study. Given that tear production
was signiﬁcantly lower in the non-SS ADDE group than in
the MGD group, the concentration of dye was likely higher
in the non-SS ADDE group than in the MGD group. More-
over, the ﬂuorescein staining score was signiﬁcantly higher in
the non-SS ADDE group than in the MGD group. A higher
effective concentration of ﬂuorescein and more severe ocular
surface epithelial damage indicated by the higher ﬂuoresceinTable 2. Clinical Parameters for th
Parameter Normal Non-S
No. of subjects 70
Age (yrs) 65.0  7.1 62.1
Symptom score (0e14) 1.0  1.3 4.9
Lid margin score (0e4) 0.3  0.5 1.7
Fluorescein score (0e9) 0.0  0.2 4.0
Tear ﬁlm break-up time (seconds) 6.0  1.7 2.1
Meiboscore (0e6) 1.1  0.8 2.2
Schirmer’s test value (mm) 10.3  3.0 2.3
Meibum grade (0e3) 0.4  0.5 0.7
Non-SS ADDE ¼ Non-Sjogren Syndrome aqueous deﬁcient dry eye; MGD ¼
Data are means  standard deviation.
930score thus may contribute to the instability of the tear ﬁlm in
the non-SSADDEgroup.We did notmeasure the thickness of
the oily layer in the present study. Further studies thus are
warranted to measure this parameter and to determine its
relationship to TBUT in each group of subjects.
There was no signiﬁcant difference in the ocular symp-
tom score between the MGD group and the non-SS ADDE
group, whereas the ﬂuorescein score in the latter group was
signiﬁcantly higher than that in normal controls or the MGD
group. Epithelial disorders at the ocular surface thus were
associated with symptoms in the non-SS ADDE group. Ine 4 Groups of Study Subjects
S ADDE MGD Non-SS ADDE and MGD
41 70 17
 9.9 66.0  8.7 72.4  7.8
 2.1 4.5  3.5 6.5  2.9
 0.9 2.4  1.0 2.6  1.1
 2.0 0.7  0.8 3.1  2.1
 1.1 3.5  2.1 1.5  0.8
 1.2 4.1  1.3 2.8  1.0
 1.7 12.5  7.6 2.8  1.7
 0.6 1.8  0.8 2.3  0.5
meibomian gland dysfunction.
Table 3. P Values for Statistical Comparison of Clinical Parameters among Subject Groups with the Steel-Dwass Test
Parameter
Normal vs.
Non-SS ADDE Normal vs. MGD
MGD vs. Non-SS
ADDE
Non-SS ADDE
vs. Non-SS
ADDE and MGD
MGD vs. Non-SS
ADDE and MGD
Normal vs.
Non-SS ADDE
and MGD
Age 0.4873 0.9265 0.2575 0.0023 0.0402 0.005
Symptom score <0.0001 <0.0001 0.762 0.2374 0.0919 <0.0001
Lid margin score <0.0001 <0.0001 0.0012 0.0105 0.8717 <0.0001
Fluorescein score <0.0001 <0.0001 <0.0001 0.1842 <0.0001 <0.0001
Tear ﬁlm break-up
time
<0.0001 <0.0001 0.0061 0.2600 0.0017 <0.0001
Meiboscore <0.0001 <0.0001 <0.0001 0.1259 0.0012 <0.0001
Schirmer’s test
value
<0.0001 0.7891 <0.0001 0.7214 <0.0001 <0.0001
Meibum grade 0.0203 <0.0001 <0.0001 <0.0001 0.0723 <0.0001
Non-SS ADDE ¼ Non-Sjogren Syndrome aqueous deﬁcient dry eye; MGD ¼ meibomian gland dysfunction.
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high, whereas the ﬂuorescein score was low. Such a
discrepancy between subjective symptoms and objective
signs is observed frequently in the clinic. The reason why
the ocular symptom score was high in the MGD group is
unclear, but it may be related to sensory nerve stimulation in
the vicinity of meibomian glands. Although information is
available regarding the release of neurotransmitters from
such nerve ﬁbers and the expression of corresponding
receptors,29e32 little is known about the consequences of
such transmission. Nerve endings have been found to form a
nerve plexus around the ducts and acini of meibomian
glands. The abnormalities of meibomian glands in patients
with MGD thus may result in the stimulation of these nerveFigure 5. Scatterplot showing the meiboscore and Schirmer’s test values for
each of the 4 groups of study subjects. Open circles and dotted lines represent
normal control (Ctrl) subjects (y ¼ e0.155x þ 10.40, R2 ¼ 0.0019,
P¼ 0.492), open triangles and dashed line represent noneSjögren syndrome
(non-SS) aqueous-deﬁcient dry eye (ADDE) subjects (y¼ 0.318xþ 1.5775,
R2¼ 0.0470, P¼ 0.115), closed squares and solid line represent meibomian
gland dysfunction (MGD) subjects (y ¼ 2.975x þ 0.219, R2 ¼ 0.2527,
P¼ 8.3106), and closed diamonds and dotted-dashed lines represent non-
SSADDE andMGD subjects (y¼ 0.668xþ 0.918,R2¼ 0.1483, P¼ 0.115).ﬁbers and thereby give rise to the ocular symptoms reported
by such individuals. Characterization of the mechanism of
tear ﬁlm compensation by increased tear secretion will
require identiﬁcation of signaling systems activated in
response to dryness at the ocular surface or tear ﬁlm insta-
bility. The sensory system for detection of ocular surface
abnormalities is thought to include corneal or conjunctival
nociception. Recent studies also indicate that thermal noci-
ception at the ocular surface is regulated by transient re-
ceptor potential channel proteins.33,34 Sensory and
transduction systems for the detection of ocular surface
abnormalities may play key roles in maintenance of the
ocular surface condition as well as in the pathogenesis of
ocular surface disorders.
Current treatments for dry eye or MGD are targeted to
improvement of the corresponding abnormal components of
the tear ﬁlm. Treatments for patients with non-SS ADDE thus
include administration of the aqueous component in the form
of artiﬁcial tears as well as the insertion of punctal plugs,
whereas those for patients with MGD include administration
of the oily component in the form of eye ointment. We
showed that the reduced function of the oily layer of the tear
ﬁlm in patients with MGD is compensated for by an
increased secretion of tear ﬂuid, suggesting that maintenance
of the balance between tear ﬁlm components may be
important for stability of the tear ﬁlm. Indeed, the adminis-
tration of eye ointment alone for patients with MGD previ-
ously was shown to worsen their symptoms and ﬁndings if
the tear volume was not sufﬁcient.35 In such cases, the
addition of not only eye ointment but also artiﬁcial tears
improved subjective symptoms and objective ﬁndings. We
also propose that treatment of tear diseases focus on
improvement of the balance between tear ﬁlm components.
Such a treatment strategy requires clinical evaluation of
tear parameters to identify the abnormality. The common
aim of present and future dry eye treatments thus should be
to maintain or recover homeostasis of the tear ﬁlm.
Further investigations of tear ﬁlm homeostasis might
consider the contributions of mucin, tear osmolarity, and
blinking. Mucin plays a key role in tear stability,36 but it is
difﬁcult to evaluate clinically. We therefore performed the
present study with the assumption that mucin kinetics are931
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Tear osmolarity, which is thought to play a major role in the
vicious circle that underlies the pathologic features of dry
eye disease,36 has been found to be related to goblet cell
density or to a mucin reduction. Furthermore, tear
osmolarity tends to be increased in patients with
MGD.6,17,37,38 Increased tear ﬂuid secretion in such pa-
tients therefore may maintain tear osmolarity. Blinking is a
physical movement to distribute tear ﬂuid over the ocular
surface. Blinking rate39 and blinking tension40 therefore are
thought to affect the condition of the tear ﬁlm. Moreover,
complete blinking is necessary to stabilize the tear ﬁlm.41
Forceful closure of the eyelids was found to increase
meibomian gland secretion and the thickness of the oily
layer of the tear ﬁlm.40 Blinking itself thus may represent
an important compensatory mechanism distinct from that
operative at the level of tear ﬁlm components in the
maintenance of tear ﬁlm homeostasis.
We enrolled only age-matched female subjects in the
present study to minimize variability in hormonal effects on
lacrimal and meibomian glands.10,42,43 Our preliminary data
indicated that male subjects are similar to females with re-
gard to the ﬁndings of the present study. In conclusion, our
present results suggested that a homeostatic system operates
in the tear ﬁlm, with tear secretion increasing to compensate
for a deﬁciency of the oily layer by increasing tear ﬁlm
stability. Our ﬁndings thus reveal the importance of main-
taining a balance between tear ﬁlm components. Further
studies are necessary to establish the operation of this
compensatory mechanism and to provide additional insight
into various aspects of tear ﬁlm homeostasis, including
blinking, tear osmolarity, the condition of the mucin layer,
and the presence of inﬂammatory factors.References
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